Skip to main content

URMC Logo

URMC / Research / Research@URMC
Targeting Metabolic Syndrome to Treat Multiple Signs of Aging

Targeting Metabolic Syndrome to Treat Multiple Signs of Aging

A recent study by University of Rochester School of Medicine and Dentistry researchers published in the International Journal of Geriatric Psychiatry begins to unravel the relationship between metabolic syndrome, frailty and cognition. The authors found that having metabolic syndrome significantly increased the chances of becoming physically frailer and slower in cognitive abilities, such as slower in recalling something that happened half an hour ago.

6/4/2014
It takes two to tango in HIV-associated brain damage

It takes two to tango in HIV-associated brain damage

HIV-associated brain damage occurs extensively, even in patients who are taking otherwise effective traditional anti-HIV therapy. This is a result of potent cooperation between two types of special immunological cells within the brain called monocytes and platelets. A recent paper published by University researchers in the Journal of Immunology demonstrates the presence of these platelet-monocyte ‘teams’ in HIV infected individuals and how these teams lead to increased neuronal damage.

 

6/3/2014
Concussion Expert Invited to White House Summit

Concussion Expert Invited to White House Summit

URMC scientist Jeffrey Bazarian, M.D., M.P.H., was at the White House today as President Obama picked up the national conversation on sports concussions.

5/29/2014
Eating Disorders: Research Roundup

Eating Disorders: Research Roundup

Eating disorders such as anorexia and bulimia affect both emotional and physical health of a person. They are amongst the most pressing adolescent health problems affecting our population. University researchers publish a timely update on these eating disorders.

5/21/2014
New Drug Improves Rare Heart Disorder, But Could Tackle Common Heart Problems, Too

New Drug Improves Rare Heart Disorder, But Could Tackle Common Heart Problems, Too

Researchers believe that a drug for a group of rare, inherited heart rhythm disorders called Long QT syndromes could also help patients with much more common cardiac arrhythmias. 

5/20/2014